Monotherapy or combination antibiotic therapy in the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia
- PMID: 37737175
- PMCID: PMC10515256
- DOI: 10.1186/s13054-023-04656-7
Monotherapy or combination antibiotic therapy in the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia
Conflict of interest statement
The authors declare that they have no competing interests.
Comment on
-
Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial.Crit Care. 2023 May 30;27(1):211. doi: 10.1186/s13054-023-04457-y. Crit Care. 2023. PMID: 37254209 Free PMC article. Clinical Trial.
References
-
- Foucrier A, Dessalle T, Tuffet S, Federici L, Dahyot-Fizelier C, Barbier F, Pottecher J, Monsel A, Hissem T, Lefrant JY, et al. Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial. Crit Care. 2023;27(1):211. doi: 10.1186/s13054-023-04457-y. - DOI - PMC - PubMed
-
- Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med. 2007;35(8):1888–1895. doi: 10.1097/01.CCM.0000275389.31974.22. - DOI - PubMed
-
- Huh K, Chung DR, Ha YE, Ko JH, Kim SH, Kim MJ, Huh HJ, Lee NY, Cho SY, Kang CI, et al. Impact of difficult-to-treat resistance in gram-negative bacteremia on mortality: retrospective analysis of nationwide surveillance data. Clin Infect Dis. 2020;71(9):e487–e496. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
